|
Lupus Landmark Study: A Prospective Registry and Biorepository
RECRUITINGSponsored by Lupus Research Alliance
Actively Recruiting
SponsorLupus Research Alliance
Started2023-06-28
Est. completion2035-12
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →
NCT05934149
Summary
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Eligibility
Age: 18 Years – 110 YearsHealthy volunteers accepted
Inclusion Criteria: * Able to understand and comply with study procedures and voluntarily sign a written informed consent document * Age 18 years or older at the time of enrollment * Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment. Exclusion Criteria: * Not able to obtain consent * Not able to meet protocol visit requirements * Pregnant at the time of enrollment
Conditions4
LupusLupus NephritisNeuropsychiatric Systemic Lupus ErythematosusSystemic Lupus Erythematosus (SLE)
Locations16 sites
Wallace Rheumatic Studies Center
Beverly Hills, California, 90210
Karla Alvarezkarla@danielwallacemd.com
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorLupus Research Alliance
Started2023-06-28
Est. completion2035-12
Eligibility
Age18 Years – 110 Years
Healthy vol.Accepted
Locations16 sites
View on ClinicalTrials.gov →
NCT05934149